<p>尽管已经有了强劲的表现，<strong>强枫控股有限公司</strong>（SGX:5TT）的股票仍在持续上涨，过去三十天上涨了 37%。上个月的表现为过去一年 163% 的大幅增长画上了句号。</p>
<p>即使在如此大幅的价格跳升之后，您仍然可以对强枫控股的市销率为 0.3 倍感到无所谓，因为新加坡建筑行业的市销率中位数也接近 0.8 倍。虽然这可能不会引起任何关注，但如果市销率没有合理的依据，投资者可能会错过潜在的机会或忽视即将到来的失望。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>查看我们对强枫控股的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/144472240-ps-multiple-vs-industry-1-dark-2/1758320178925?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/144472240-ps-multiple-vs-industry-1-dark-2/1758320178925"/></p>
<p>SGX:5TT 市销率与行业比较 2025 年 9 月 19 日</p>
<h3>强枫控股最近的表现如何？</h3>
<p>强枫控股在过去一年实现的收入增长对于大多数公司来说都是相当可接受的。许多人可能预期可观的收入表现会减弱，这使得市销率未能上升。如果您喜欢这家公司，您会希望这种情况不会发生，以便在公司尚未受到青睐时能够买入一些股票。</p>
<p>尽管没有强枫控股的分析师预测，但请查看这个 <strong>免费的</strong> 数据丰富的可视化图表，看看该公司在收益、收入和现金流方面的表现。</p>
<h2>收入增长指标告诉我们关于市销率什么？</h2>
<p>有一个内在的假设，即公司应该与行业的市销率相匹配，像强枫控股这样的市销率才被认为是合理的。</p>
<p>回顾过去一年，该公司的收入增长达到了 24% 的显著增幅。最近三年期间，收入也实现了 83% 的整体增长，这得益于其短期表现。因此，股东们肯定会欢迎这些中期的收入增长率。</p>
<p>有趣的是，行业的其他部分预计在未来一年也将增长 22%，这与该公司最近的中期年化增长率相当接近。</p>
<p>鉴于此，强枫控股的市销率与大多数其他公司保持一致是可以理解的。似乎大多数投资者预计未来将继续看到平均增长率，并且只愿意为该股票支付适度的价格。</p>
<h2>我们可以从强枫控股的市销率中学到什么？</h2>
<p>其股票大幅上涨，现在强枫控股的市销率已回到行业中位数的范围内。有人认为市销率在某些行业中是一个较差的价值衡量标准，但它可以是一个强有力的商业情绪指标。</p>
<p>我们认为，强枫控股保持其适度的市销率是因为其最近三年的增长与更广泛的行业预测相符。目前，过去的收入趋势与行业前景紧密相连，股东们对公司的未来收入前景没有重大意外的信心。如果最近的中期收入趋势持续下去，在这种情况下，股价很难在短期内强劲波动。</p>
<p>不要忘记可能还有其他风险。例如，我们已经识别出 <strong>强枫控股的 3 个警告信号</strong>（其中 1 个令人担忧），您应该注意。</p>
<p>如果您对强枫控股的业务实力 <strong>不确定</strong>，为什么不探索我们互动的股票列表，寻找一些您可能错过的具有良好商业基础的其他公司呢？</p>

强枫

<p>Keong Hong Holdings Limited（新交所代码：5TT）的股价在过去一个月上涨了 37%，在过去一年中更是实现了惊人的 163% 的增长。尽管如此，该公司的市销率（P/S 比率）为 0.3 倍，低于行业中位数的 0.8 倍，这表明投资者可能持谨慎态度。公司显示出强劲的收入增长，过去一年增长了 24%，三年内增长了 83%。投资者似乎预期将继续保持平均增长，因此市销率保持在适中水平。然而，需要考虑的风险包括公司已识别的警示信号</p>

<p>Despite an already strong run, <strong>Keong Hong Holdings Limited</strong> (SGX:5TT) shares have been powering on, with a gain of 37% in the last thirty days. The last month tops off a massive increase of 163% in the last year.</p>
<div class="lb-trans"><p>尽管已经有了强劲的表现，<strong>强枫控股有限公司</strong>（SGX:5TT）的股票仍在持续上涨，过去三十天上涨了 37%。上个月的表现为过去一年 163% 的大幅增长画上了句号。</p>
</div><p>Even after such a large jump in price, you could still be forgiven for feeling indifferent about Keong Hong Holdings' P/S ratio of 0.3x, since the median price-to-sales (or &#34;P/S&#34;) ratio for the Construction industry in Singapore is also close to 0.8x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.</p>
<div class="lb-trans"><p>即使在如此大幅的价格跳升之后，您仍然可以对强枫控股的市销率为 0.3 倍感到无所谓，因为新加坡建筑行业的市销率中位数也接近 0.8 倍。虽然这可能不会引起任何关注，但如果市销率没有合理的依据，投资者可能会错过潜在的机会或忽视即将到来的失望。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>See our latest analysis for Keong Hong Holdings</p>
<div class="lb-trans"><p>查看我们对强枫控股的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/144472240-ps-multiple-vs-industry-1-dark-2/1758320178925" alt="" original-src="https://images.simplywall.st/asset/chart/144472240-ps-multiple-vs-industry-1-dark-2/1758320178925"/></p>
<p>SGX:5TT Price to Sales Ratio vs Industry September 19th 2025</p>
<div class="lb-trans"><p>SGX:5TT 市销率与行业比较 2025 年 9 月 19 日</p>
</div><h3>How Has Keong Hong Holdings Performed Recently?</h3>
<div class="lb-trans"><h3>强枫控股最近的表现如何？</h3>
</div><p>The revenue growth achieved at Keong Hong Holdings over the last year would be more than acceptable for most companies. It might be that many expect the respectable revenue performance to wane, which has kept the P/S from rising. If you like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's not quite in favour.</p>
<div class="lb-trans"><p>强枫控股在过去一年实现的收入增长对于大多数公司来说都是相当可接受的。许多人可能预期可观的收入表现会减弱，这使得市销率未能上升。如果您喜欢这家公司，您会希望这种情况不会发生，以便在公司尚未受到青睐时能够买入一些股票。</p>
</div><p>Although there are no analyst estimates available for Keong Hong Holdings, take a look at this <strong>free</strong> data-rich visualisation to see how the company stacks up on earnings, revenue and cash flow.</p>
<div class="lb-trans"><p>尽管没有强枫控股的分析师预测，但请查看这个 <strong>免费的</strong> 数据丰富的可视化图表，看看该公司在收益、收入和现金流方面的表现。</p>
</div><h2>What Are Revenue Growth Metrics Telling Us About The P/S?</h2>
<div class="lb-trans"><h2>收入增长指标告诉我们关于市销率什么？</h2>
</div><p>There's an inherent assumption that a company should be matching the industry for P/S ratios like Keong Hong Holdings' to be considered reasonable.</p>
<div class="lb-trans"><p>有一个内在的假设，即公司应该与行业的市销率相匹配，像强枫控股这样的市销率才被认为是合理的。</p>
</div><p>Retrospectively, the last year delivered an exceptional 24% gain to the company's top line. The latest three year period has also seen an excellent 83% overall rise in revenue, aided by its short-term performance. Accordingly, shareholders would have definitely welcomed those medium-term rates of revenue growth.</p>
<div class="lb-trans"><p>回顾过去一年，该公司的收入增长达到了 24% 的显著增幅。最近三年期间，收入也实现了 83% 的整体增长，这得益于其短期表现。因此，股东们肯定会欢迎这些中期的收入增长率。</p>
</div><p>It's interesting to note that the rest of the industry is similarly expected to grow by 22% over the next year, which is fairly even with the company's recent medium-term annualised growth rates.</p>
<div class="lb-trans"><p>有趣的是，行业的其他部分预计在未来一年也将增长 22%，这与该公司最近的中期年化增长率相当接近。</p>
</div><p>In light of this, it's understandable that Keong Hong Holdings' P/S sits in line with the majority of other companies. It seems most investors are expecting to see average growth rates continue into the future and are only willing to pay a moderate amount for the stock.</p>
<div class="lb-trans"><p>鉴于此，强枫控股的市销率与大多数其他公司保持一致是可以理解的。似乎大多数投资者预计未来将继续看到平均增长率，并且只愿意为该股票支付适度的价格。</p>
</div><h2>What We Can Learn From Keong Hong Holdings' P/S?</h2>
<div class="lb-trans"><h2>我们可以从强枫控股的市销率中学到什么？</h2>
</div><p>Its shares have lifted substantially and now Keong Hong Holdings' P/S is back within range of the industry median. It's argued the price-to-sales ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.</p>
<div class="lb-trans"><p>其股票大幅上涨，现在强枫控股的市销率已回到行业中位数的范围内。有人认为市销率在某些行业中是一个较差的价值衡量标准，但它可以是一个强有力的商业情绪指标。</p>
</div><p>It appears to us that Keong Hong Holdings maintains its moderate P/S off the back of its recent three-year growth being in line with the wider industry forecast. Currently, with a past revenue trend that aligns closely wit the industry outlook, shareholders are confident the company's future revenue outlook won't contain any major surprises. If recent medium-term revenue trends continue, it's hard to see the share price moving strongly in either direction in the near future under these circumstances.</p>
<div class="lb-trans"><p>我们认为，强枫控股保持其适度的市销率是因为其最近三年的增长与更广泛的行业预测相符。目前，过去的收入趋势与行业前景紧密相连，股东们对公司的未来收入前景没有重大意外的信心。如果最近的中期收入趋势持续下去，在这种情况下，股价很难在短期内强劲波动。</p>
</div><p>Don't forget that there may be other risks. For instance, we've identified <strong>3 warning signs for Keong Hong Holdings</strong> (1 is concerning) you should be aware of.</p>
<div class="lb-trans"><p>不要忘记可能还有其他风险。例如，我们已经识别出 <strong>强枫控股的 3 个警告信号</strong>（其中 1 个令人担忧），您应该注意。</p>
</div><p>If you're <strong>unsure about the strength of Keong Hong Holdings' business</strong>, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.</p>
<div class="lb-trans"><p>如果您对强枫控股的业务实力 <strong>不确定</strong>，为什么不探索我们互动的股票列表，寻找一些您可能错过的具有良好商业基础的其他公司呢？</p>
</div>

投资者似乎对 Keong Hong Holdings Limited（SGX:5TT）的前景感到满意，其股价飙升了 37%